A recent approach is the administration of BMP-7 (bone morphogenetic protein 7), which, in mice, showed the potential to attenuate pyroptosis, inflammation, and muscle atrophy in diabetic muscle myopathy via the inhibition of the HMGB-1 protein. Here, BMP7 is linked to muscle atrophy.